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Abstract. – OBJECTIVE: Aim of this study is
to evaluate the possibility of limb magnetic reso-
nance lymphography (MRL) to differentiate lym-
phatic vessels from pathological veins, collect a
specimen of the identified lymphatic vessel dur-
ing operations of super microsurgical lymphatic-
venular anastomosis (s-LVA) and perform im-
munohistochemical stainings to confirm the na-
ture of the collected vessels.
PATIENTS AND METHODS: Twenty patients
presenting lymphedema were enrolled in this
study. Five patients reported lower limb lym-
phedema and 15 patients reported upper limb
lymphedema. All patients had the indication for
s-LVA and underwent preoperative MRL imaging
of the affected limb. A total of 57 lymphatic ves-
sels were identified by MRL and used to guide s-
LVA: all these vessels have also been used to
perform an intraoperative biopsy for immunohis-
tochemical evaluation.
RESULTS: A total of 53/57 vascular structures
resulted compatible with lymphatic vessels at
the immunohistochemical study performed with
D2-40 antibody; 3/57 specimen showed the ab-
sence of the D2-40 antibody. A significant asso-
ciation was found between preoperative MRL
and immunohistochemical marker D2-40 on col-
lected specimen.
CONCLUSIONS: Most of the articles in the in-
ternational literature report the concomitant
presence of both lymphatic and venous vessels
at MRL. However, no one in literature describes
the possibility to differentiate venous vessels
from lymphatic vessels, and this is a crucial is-
sue for the correct evaluation of the lymphatic
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system in patients with limb lymphedema under-
going a future surgical correction. In the present
study, MRL allowed to identify active lymphatic
vessels. MRL was predictive to determine preop-
eratory lymphatic vessels and to perform suc-
cessful s-LVA in lymphedema patients. This is
the first study to prove the nature of the vessels





Lymphedema is a pathology characterized by
a limb accumulation of subcutaneous protein-
rich fluid due to a lymphatic system disorder.
While primary lymphedema is characterized by
congenital abnormalities, secondary lymphedema
is caused in most cases by obstruction or stenosis
of lymph vessels caused by surgical oncology1.
Lymphatic-venular anastomosis (LVA) is a
microsurgical technique effective to improve
limb circumference and to alleviate dermal scle-
rosis2,3. Super microsurgical lymphatic-venular
anastomosis (s-LVA) is an advanced technique
that allows to perform an anastomosis on even
smaller vessels, and showed good results in
lymphedema patients to reduce limb circumfer-
ence and cellulitis4.
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To perform LVA or s-LVA, the preoperative
lymphatic mapping is necessary for surgical plan-
ning: the ideal imaging technique to evaluate lym-
phedema has been, for many years, lymphoscintig-
raphy, using a radionuclide with various 99mTc-la-
belled molecules5. Recently, Indocyanine Green
(ICG) lymphography has been introduced6.
Magnetic Resonance Lymphography (MRL)
performed with injections of gadolinium-based
contrast agent has been widely described in the
literature with gadolinium contrast enhancement,
injecting the contrast in the interdigital spaces.
Its use is mainly related to the lymphedema and
the imaging of the lymphatic system, and it is
crucial to understand lymphatic vessels role in
the disease development and to plan the opera-
tion. The main difficulty of MRL imaging is the
differential diagnosis between lymphatic vessels
and venous vessels.
In the present paper, the authors have intended
to verify the accuracy of preoperative MRL per-
forming a biopsy of the lymphatic vessels for im-
munohistochemical study (D2-40 antibody) dur-
ing operations of s-LVA in lymphedema patients.
Patients and Methods
The present study included 20 female patients
with a mean age of 57.6 years old affected by
lymphedema (3 cases of primary lymphedema,
17 cases of secondary lymphedema). These pa-
tients underwent to a MRL before operation of s-
LVA. During the s-LVA operations specimen of
the MRL-presumed lymphatic vessels were col-
lected and sent to the laboratory for immunohis-
tochemical stainings.
Magnetic Resonance Lymphography
Before MRLA, interdigital injection of
gadolinium-based contrast agent was performed
using the most commercially available and wide-
ly diffused paramagnetic contrast medium:
Gadobenate Dimeglumine (Gd-BOPTA, Multi-
hance, Bracco Imaging, Milan, Italy). The solu-
tion to inject was prepared with 15 mL of
gadobenate dimeglumine (that corresponds to
one bottle) and 1.5 mL of lidocaine (1% solu-
tion), then the mixed agent was injected intracu-
taneously into the interdigital webs of the dorsal
foot, with four injections for each limb. The vol-
ume injected into each point was 0.7 to 0.8 mL.
All magnetic resonance (MR) exams were per-
formed with a 1.5 Tesla MR unit (Signa Twin
Speed Hdxt; General Electric Healthcare, Mil-
waukee, WI, USA), with a maximum gradient
strength of 23 mT/m and a slew rate of 80
mT/m/ms (software release 15.0_0947A). Pa-
tients were supine, feet first, with both legs on a
ramp pillow in order to obtain a parallelism with
the main magnetic field and to position them on
the most homogeneous area of the B0. To obtain
a large anatomical coverage and a good signal-
to-noise ratio, a 7000-elements phased array pe-
ripheral vascular receiving coil (Flow 7000) for
the study of the lower extremity and a 8 channel
Body Array for the upper extremity were used;
both of them are built by USA Instrument. The
fingers appeared from the holes of the coil, let-
ting them to be out for an easy access during the
injections of the contrast agent. To reduce the hy-
perintensity artifacts we paid attention to avoid
direct contact of the coil surface with the patient
extremity, using some small pillows. Patients
were instructed on the procedure in order to ob-
tain complete collaboration.
After positioning a survey and calibration
from all the stations, three for the lower extremi-
ty (foot-ankle calf, calf knee, thigh hip) and two
or three for the upper extremity (hand-wrist fore-
arms, elbow arm shoulder) were performed. Sub-
sequently, before the injection of the contrast
agent, a coronal 3D SSFP Balanced (Fiesta, GE)
ECG-triggered with spectral fat saturation
(SPECtral Inversion At Lipidi, SPECIAL, GE)
was acquired; the technical parameters used
were: TR 4.0 ms, TE 1.9 ms, TI 90 ms, FOV 40
× 40 cm, Matrix 224 × 192, slice thickness 2.2
mm, NEX 0.53 (Half Fourier) and Bandwidth
kHz. The ECG trigger was acquired with a Pe-
ripheral Gating (PG, GE) and a Delay Time set
for a systolic phase acquisition in order to obtain
a no contrast venography (the high flow artery
experienced some flow dephasing reducing their
signal); we also obtained a good image to visual-
ize the lymphoedema.
For dynamic MRL, 3D fast spoiled gradient-
recalled echo T1-weighted images with a fat sat-
uration technique (T1 high-resolution isotropic
volume excitation) were acquired in every station
at 5, 10, 15, 20, 25, 30, 35 and 40 minutes ap-
proximately after contrast injection. The techni-
cal parameters were: f TR/TE 5.0 ms/2.1 ms; TI
17 ms, flip angle 25 , FOV 480 × 480 mm, ma-
trix 448 × 320, slice thickness 2.2 mm, NEX
(signal average number) 2 and Bandwidth kHz,
acquisition time 0 min 40 sec. The 3D MRL
were then reconstructed from the post-contrast
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serum albumin)7. The sections were then incubat-
ed 10 min in the dark with the secondary anti-
body (biotinylated goat anti mouse IgG of the
same kit). The reaction was revealed by a 10 min
incubation with streptavidin horseradish peroxi-
dase diluted in Tris Buffered Saline followed by
a 2 min incubation with 3,3’-diaminobenzidine
Substrate Kit for Peroxidase (VECTOR), which
contains a nickel solution that converts the brown
color characteristic of 3,3’-diaminobenzidine in
black. Sections were counterstained with May-
er’s hematoxylin and mounted with Eukitt (Sig-
ma, St Louis, MO, USA).
Data Analysis
After data acquisition, image post-processing
and subsequent analysis were performed by two
experienced radiologists, who reached an agree-
ment by consensus. At MRLA examination af-
fected lymphatic vessels were distinguished from
a vein because of their caliber (diameter) and
their morphology.
Differences between groups were evaluated
using chi-square test. Association between vari-
ables were tested by univariate regression analy-
sis. p-values < 0.05 were considered to be signifi-
cant if not otherwise specified.
Results
No complications were observed after the ex-
amination, in particular, no complications were
observed during or after intracutaneous injec-
tions of Gd-BOPTA. The lymphedema showed
an epifascial distribution with a high signal in-
tensity on Coronal 3D SSFP Balanced images.
Affected lymphatic vessels were distinguished
from veins because of their caliber and their
morphology; in particular the diameter of the
ectasic lymphatic vessels was smaller than the
one of the adjacent vein and greater than the
one of the lymphatic vessels of the unaffected
extremity when visualized, whereas the mor-
phology was tortuous (beaded appearance) in
comparison with the morphology of the veins.
The beaded appearance of the lymphatic vessels
extending from the injection site was reliably
detected 5-10 minutes after the injection and, in
the majority of the cases, the lymphatic vessels
could be detected, with the strongest enhance-
ment at 35-40 minutes after contrast injection.
Collateral vessels with dermal backflow (an
area of progressive dispersion of the contrast
coronal images at each time point using a MIP
technique. The exam ended acquiring, in every
station, a coronal 3D Rapid Acquisition with Re-
laxation Enhancement heavily T2-weighted with
Driven Equilibrium, in order to reduce the acqui-
sition time by reducing the Repetition Time with-
out affect the images, (FRFSE T2, GE) with the
following parameters: TR 2000 ms, TE 679 ms,
FOV 48x48 cm, Matrix 320 × 256, Thickness 3.6
mm, NEX 1 and Bandwidth kHz; with these im-
ages the lymphoedema is clearly visible and
measurable. The examination time for one pa-
tient was approximately 1.5 hours. No systemic
or local complications were observed during or
after the examination.
Image Interpretation
The images analysis was then performed using
Multi Planar Reconstruction of the subtracted
images and with Thin-Slab Maximum Intensity
Projection in order to better visualize the lym-
phatic vessels.
Super Microsurgery
After the visualiation of the lymphatic vessels
using MRLA, superficial veins mapping with Ac-
cuvein device was performed to identify the mi-
crosurgical sites. Under local anaesthesia with
1% xylocaine containing adrenalin a skin inci-
sion was performed on each site, subcutaneous
tissue was dissected under a high magnification
operating microscope. Lymphatic collectors and
adjacent subcutaneous veins were identified. Ves-
sels were dissected and 4 or 5 11/0 endoluminal
sutures with a 50-micron needle were performed
between lymphatic and venous vessels (Figure
1). Afterwards, the skin was stitched up with
continuous 6/0 resorbable microsutures.
Immunohistochemistry
Specimens were formalin fixed and paraffin
embedded. Consecutive sections were obtained
from each sample, dewaxed with xylene and re-
hydrated in descending ethanol series. Endoge-
nous peroxidases were blocked with 3% hydro-
gen peroxide. Non-specific binding sites were
blocked by a 5 min incubation with Blocking
Reagent (IHC SelectTM kit, Millipore, Billerica,
MA, USA) followed by a brief wash in PBS
(Phosphate Buffered Saline). The sections were
then incubated overnight with the primary anti-
body D2-40, a monoclonal IgG1 specific for the
lymphatic endothelium (Dako, Santa Clara, CA,
USA, diluted 1:20 in PBS containing 1% bovine
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medium between lymphatic vessels in the soft
tissues), indicating proximal lymph flow ob-
struction with alternate pathways of transport,
were generally seen after 15-20 minutes (Figure
2). The mean diameter of a dilated lymphatic
vessel was 2.20 ± 0.5 mm. The mean diameter
of a venous vessel was 2.4 ± 0.2 mm.
No complications were showed after s-LVA;
mean hospitalization was 2 days. No correlation
between age and results was found. A total of 57
(2.85 per patient mean) lymphatic vessels were
identified at the preoperative MRL; among these
53/57 specimen collected of these vessels result-
ed positive at the immunohistochemical marker
D2-40 (Figure 2, Figure 3). A significant associa-
tion was found between preoperative MRI and
immunohistochemical marker D2-40 on collect-
ed specimen (Chi-square = 40.421, DF = 1, Sig-
nificance level p < 0.0001, contingency coeffi-
cient 0.644).
Discussion
Lymphoscintigraphy has been for many years
the gold standard imaging in lymphoedema pa-
tients; however, radiation exposure, long exami-
nation time needed, side effects such as pul-
monary embolism have limited its clinical applic-
ability8.
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Figure 1. Intraoperative image of the super microsurgical lymphatic-venular anostomosis (s-LVA) during the collection of
biopsy specimen.
Lohrmann et al9-11 in their papers reported the
visualization of venous vessels at MRL, as con-
trast may be captured by both lymphatic and ve-
nous capillaries: venous vessels resulted to be
contrast-enhanced faster than lymphatic vessels,
which resulted slower.
At the Lymphoedema Mondial Congress in
Rome in 2013, and at the International Lym-
phoedema Congress in Genova in 2014, many
criticisms have been raised against the use of the
MRL and the potential discrimination between
lymphatic and venous vessels.
Most of the articles present in the international
literature report the concomitant presence of both
lymphatic and venous vessels in MRL. Lohrmann
et al7 and Ruehm et al12 reported some suggestions
to differentiate lymphatic and venous vessels.
However these criteria may be not enough, due to
the concomitant dysfunction of deep and superfi-
cial venous circulation, the identified structures
may easily be dysfunctional venous vessels
(closed or thrombosed veins, varicose veins or
valvular insufficiency). Further resonance imaging
of lymphatic vessels may be even more doubtful
on nonedematous limbs9. The most of the pub-
lished papers suppose to identify the lymphatic
vessels mostly due to their ectasic morphology,
without any laboratory confirmation.
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Figure 2. A, Preoperative magnetic resonance lymphography (MRL) of the affected limb. B, Intraoperative s-LVA image. C,




MRL imaging is a relatively new technique
used to map the lymphatic vessels injecting con-
trast material, accompanied by high-resolution
sequential 3D imaging of the affected organ. It is
well known that the advantage of this technique
is that it allows dynamic monitoring of the lym-
phatic transit with simple and minimally invasive
high-spatial- and high-temporal-resolution imag-
ing techniques to visualize the lymphatic system.
However, no one in literature describes the possi-
bility to differentiate venous vessels from lym-
phatic vessels and this is a crucial issue to cor-
rectly evaluate the lymphatic system in patients
with limb lymphedema undergoing future surgi-
cal correction13,14.
S-LVA is a super microsurgical technique ef-
fective to improve limb circumference, alleviate
dermal sclerosis and reduce cellulitis in lym-
phoedema patients2,3,15: to perform s-LVA preop-
erative lymphatic mapping is necessary for surgi-
cal planning.
Our criteria for differential diagnosis between
venous and lymphatic vessels were mainly the
caliber, the morphology and the beaded appear-
ance of the vessels. The study of the unaffected
limb has been essential for the imaging and dif-
ferential diagnosis: diameter of the ectasic lym-
phatic vessels was smaller than the adiacent vein
and greater than the lymphatic vessels of the un-
affected extremity. In comparison with others au-
thors that referred their experience in MRL, their
reported criteria to distinguish veins and lym-
phatic vessels may be not effective, and especial-
ly may not be effective on healthy limbs. Liu et
al16 evidenced only 5/23 cases of contrast-en-
hanced lymphatic vessels with MRL.
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Figure 3. Another case with preoperative MRL of the affected limb. B, Intraoperative s-LVA image. C, Histological staining
of the collected lymphatic vessel.
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In this paper, we performed a biopsy to collect
a specimen of the lymphatic vessels presumed at
the MRL. Most of these specimen resulted to be
lymphatic vessels thanks to immunohistochemi-
cal stainings. For this reason, our criteria resulted
to be significantly effective limited to the cases
of this study: during s-LVA, we found a signifi-
cant number of lymphatic vessels on the basis of
preoperative MRL images. Mitsumori et al17 re-
ported their experience of MRL on four consecu-
tive patients. Mitsumori et al17 performed an in-
travenous systemic and subdermal injection of
Gd-based MR contrast and supported the idea to
identify all venous vessels that, with the techno-
logical removal of these from the structures evi-
denced with subdermal contrast, should leave on-
ly the lymphatic vessels17. However, it is possible
that a thrombosed vein (e.g. a tied saphenous vein)
could receive contrast from a cutaneous injection
but not from systemic circulation. Further, no his-
tological evidence of the identified vessels was re-
ported.
MRL with the proper criteria is a feasible
technique that studies the limb lymphatic system
with the use of commercially available contrast
agents. This technique offers a newer minimally
invasive procedure to visualize the lymphatic
system anatomy with the aim to guide surgical
operation. However, further studies enrolling
more patients should be performed to determine
the kinetics of gadolinium transport in disease
states with the high lymphatic flow.
Present diagnostic tools in order to quantify
the lymphoedema are limb circumference, self-
assessment questionnaires and water displace-
ment18: MRL may find its clinical usefulness in
the follow-up of the s-LVA and to evaluate the
flow into the anostomosis19. Further, screening of
oncological non-symptomatic patients could
highlight possible latent lymphoedema and sug-
gest conservative treatments or super microsurgi-
cal noninvasive surgery: treatment in initial lym-
phoedema has a significantly better prognosis
than in the advanced ones20.
Conclusions
In the present work, MRL revealed to be pre-
dictive to identify preoperatory lymphatic vessels
and to perform successfully s-LVA in lym-
phoedema patients. A significative number of
lymphatic vessels were found during s-LVA on
the basis of preoperatory MRL images. This is
the first single-center study that compares super
microsurgery, magnetic resonance and immuno-
histochemistry in order to perform differential di-
agnosis between lymphatic and venous vessels:
our significative results add credit to the imaging
technique and let us define MRL as a possible
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